GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Innopharmax 4172.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

9.41

+4.09%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 69.0m

FY2016FY2025

Net income

−TWD 184.4m

FY2016FY2025

Free cash flow

−TWD 134.5m

FY2016FY2025

Shareholders' equity

TWD 419.2m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 69.0mTWD 32.3mTWD 46.1mTWD 29.1mTWD 48.1mTWD 136.9mTWD 84.9mTWD 56.5mTWD 43.9mTWD 45.7m
Research and developmentTWD 155.2mTWD 89.2mTWD 59.3mTWD 71.9mTWD 60.2mTWD 62.4mTWD 86.0mTWD 76.2mTWD 124.1mTWD 121.3m
Operating income−TWD 171.8m−TWD 96.0m−TWD 64.8m−TWD 93.3m−TWD 74.4m−TWD 30.3m−TWD 74.9m−TWD 80.2m−TWD 152.9m−TWD 158.1m
Net income−TWD 184.4m−TWD 99.3m−TWD 70.8m−TWD 103.2m−TWD 93.0m−TWD 43.9m−TWD 87.9m−TWD 86.3m−TWD 161.9m−TWD 48.7m
Diluted earnings per share-1.72-0.99-0.75-1.19-0.86-0.41-0.82-1.18-2.34-0.77

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 469.0mTWD 633.1mTWD 524.2mTWD 489.3mTWD 556.2mTWD 680.2mTWD 596.7mTWD 584.1mTWD 649.7mTWD 706.3m
Cash and short-term investments—TWD 294.2mTWD 152.3mTWD 104.6mTWD 187.3mTWD 241.9mTWD 168.4mTWD 99.5mTWD 165.5mTWD 179.3m
Total liabilitiesTWD 49.8mTWD 30.2mTWD 48.6mTWD 58.3mTWD 24.6mTWD 208.6mTWD 81.4mTWD 40.9mTWD 22.0mTWD 34.2m
Debt—TWD 15.4mTWD 21.5mTWD 37.6mTWD 5.6mTWD 29.9mTWD 33.7m———
Shareholders' equityTWD 419.2mTWD 602.8mTWD 475.5mTWD 431.0mTWD 531.5mTWD 471.6mTWD 515.3mTWD 543.2mTWD 627.8mTWD 672.1m
Shares outstanding108m100m95m87m108m108m108m73m69m63m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−TWD 134.2m−TWD 76.2m−TWD 48.6m−TWD 100.1m−TWD 50.0m−TWD 47.4m−TWD 42.5m−TWD 70.2m−TWD 118.7m−TWD 156.3m
Capital spending−TWD 276,000−TWD 589,000−TWD 397,000−TWD 128,000−TWD 1.4m−TWD 1.9m—−TWD 303,000−TWD 7.0m−TWD 3.7m
Free cash flow−TWD 134.5m−TWD 76.8m−TWD 49.0m−TWD 100.2m−TWD 51.5m−TWD 49.2m−TWD 42.5m−TWD 70.5m−TWD 125.7m−TWD 160.0m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2017
RevenueTWD 46.6mTWD 9.1mTWD 23.2mTWD 11.4mTWD 34.6mTWD 14.4mTWD 14.7mTWD 5.3m
Operating income−TWD 43.8m−TWD 55.4m−TWD 40.6m−TWD 39.9m−TWD 24.9m−TWD 47.5m−TWD 45.8m−TWD 36.0m
Net income−TWD 50.2m−TWD 56.7m−TWD 42.5m−TWD 41.0m−TWD 29.9m−TWD 54.3m−TWD 48.9m−TWD 38.7m
Diluted earnings per share-0.47-0.57-0.43-0.43-0.31-0.63-0.56-0.53
Cash from operations−TWD 41.0m−TWD 57.0m−TWD 18.0m−TWD 44.0m−TWD 3.0m−TWD 54.0m−TWD 45.0m—
Total assetsTWD 595.8mTWD 633.1mTWD 478.1mTWD 524.2mTWD 546.0mTWD 489.3m——
Cash and short-term investmentsTWD 256.0mTWD 294.2mTWD 118.1mTWD 152.3mTWD 189.6mTWD 104.6m——
DebtTWD 19.6mTWD 14.6mTWD 14.6mTWD 16.1mTWD 4.5mTWD 27.7m——
Shareholders' equityTWD 553.0mTWD 602.8mTWD 433.7mTWD 475.5mTWD 515.2mTWD 431.0m——

Financial ratios

Data as of 31 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin-261.7%-299.3%-132.8%-333.3%-164.9%-24.1%—
Net margin-267.3%-307.4%-153.7%-354.2%-193.4%-32.1%—
Return on equity-44.0%-16.5%-14.9%-23.9%-17.5%-9.3%—
Return on assets-39.3%-15.7%-13.5%-21.1%-16.7%-6.5%—
Free cash flow yield-12.6%-7.7%-5.1%-11.7%———
Revenue growth113.6%-29.9%58.1%-39.4%-64.9%61.2%—
Earnings growth85.7%40.2%-31.4%11.0%111.8%-50.1%—
Current ratio3.52x10.90x5.57x3.49x14.72x1.54x—
Debt to equity—0.02x0.03x0.06x0.01x0.05x0.05x
Equity ratio89.4%95.2%90.7%88.1%95.6%69.3%—
Interest coverage-471.30x-314.85x-166.20x-377.84x-199.11x-53.32x—
R&D as a share of sales225.0%276.2%128.8%247.0%125.3%45.6%—
Buybacks as a share of market value-7.6%-5.1%-9.6%————

Growth per year

Compound annual rate

3 years5 years10 years
Revenue33.3%-12.8%4.5%
Operating income22.5%41.5%2.8%
Net income21.4%33.2%3.9%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-264.3%-241.3%-146.8%-177.1%
Net margin-280.1%-259.3%-164.5%-173.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-9.8-16.4-23.1-9.6-19.7-41.5-14.5-6.0-7.5-38.1
Price to sales26.250.335.634.038.113.315.09.227.840.7

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.